Middlemen are driving up the cost of life-saving drugs

The Hill

10 January 2018 - History will record 2017 as a transformative year in medicine. 

The U.S. approved the first gene therapy that modifies a patient’s blood cells to help the immune system attack an aggressive form of leukaemia in children and young adults.

Another breakthrough gene therapy was approved for a common form of lymphoma in adults, and the green light was given for a therapy that for the first time targets a specific genetic mutation.

Read The Hill article


Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Health plans , Pricing , Pharmacy